nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—CYP2B6—Irinotecan—colon cancer	0.083	0.468	CbGbCtD
Mexiletine—CYP1A2—Fluorouracil—colon cancer	0.0467	0.263	CbGbCtD
Mexiletine—CYP3A4—Irinotecan—colon cancer	0.0255	0.144	CbGbCtD
Mexiletine—CYP3A4—Vincristine—colon cancer	0.0223	0.126	CbGbCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—RAD54L—colon cancer	0.0134	0.0745	CbGpPWpGaD
Mexiletine—Speech impairment NOS—Methotrexate—colon cancer	0.0125	0.0206	CcSEcCtD
Mexiletine—Pulmonary toxicity—Methotrexate—colon cancer	0.012	0.0198	CcSEcCtD
Mexiletine—Lung infiltration—Irinotecan—colon cancer	0.0116	0.0192	CcSEcCtD
Mexiletine—Oesophageal ulcer—Capecitabine—colon cancer	0.01	0.0166	CcSEcCtD
Mexiletine—Arrhythmia supraventricular—Capecitabine—colon cancer	0.00942	0.0156	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—ODC1—colon cancer	0.00811	0.0451	CbGpPWpGaD
Mexiletine—Nystagmus—Vincristine—colon cancer	0.00784	0.013	CcSEcCtD
Mexiletine—Heartburn—Fluorouracil—colon cancer	0.00759	0.0126	CcSEcCtD
Mexiletine—Nystagmus—Fluorouracil—colon cancer	0.00732	0.0121	CcSEcCtD
Mexiletine—Numbness—Vincristine—colon cancer	0.00676	0.0112	CcSEcCtD
Mexiletine—Sensory loss—Vincristine—colon cancer	0.00647	0.0107	CcSEcCtD
Mexiletine—Speech disorder—Irinotecan—colon cancer	0.00634	0.0105	CcSEcCtD
Mexiletine—Numbness—Fluorouracil—colon cancer	0.0063	0.0104	CcSEcCtD
Mexiletine—Pulmonary fibrosis—Methotrexate—colon cancer	0.00618	0.0102	CcSEcCtD
Mexiletine—Speech disorder—Fluorouracil—colon cancer	0.00608	0.01	CcSEcCtD
Mexiletine—Sensory loss—Fluorouracil—colon cancer	0.00603	0.00998	CcSEcCtD
Mexiletine—Lung infiltration—Methotrexate—colon cancer	0.0058	0.00959	CcSEcCtD
Mexiletine—Hiccups—Irinotecan—colon cancer	0.00546	0.00903	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.00525	0.0292	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TOP1—colon cancer	0.00476	0.0265	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MSH6—colon cancer	0.00442	0.0246	CbGpPWpGaD
Mexiletine—Dermatitis exfoliative—Irinotecan—colon cancer	0.0042	0.00694	CcSEcCtD
Mexiletine—Visual disturbance—Irinotecan—colon cancer	0.00418	0.00691	CcSEcCtD
Mexiletine—Ventricular extrasystoles—Capecitabine—colon cancer	0.00404	0.00669	CcSEcCtD
Mexiletine—Amnesia—Fluorouracil—colon cancer	0.00404	0.00668	CcSEcCtD
Mexiletine—Ataxia—Vincristine—colon cancer	0.00382	0.00633	CcSEcCtD
Mexiletine—Coordination abnormal—Capecitabine—colon cancer	0.00372	0.00615	CcSEcCtD
Mexiletine—Hiccups—Capecitabine—colon cancer	0.00365	0.00604	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MSH2—colon cancer	0.00358	0.0199	CbGpPWpGaD
Mexiletine—Ataxia—Fluorouracil—colon cancer	0.00357	0.0059	CcSEcCtD
Mexiletine—Cramp muscle—Irinotecan—colon cancer	0.00357	0.0059	CcSEcCtD
Mexiletine—Dry skin—Fluorouracil—colon cancer	0.00348	0.00575	CcSEcCtD
Mexiletine—Pancreatitis—Irinotecan—colon cancer	0.00336	0.00555	CcSEcCtD
Mexiletine—Sweating increased—Irinotecan—colon cancer	0.00334	0.00552	CcSEcCtD
Mexiletine—Angina pectoris—Irinotecan—colon cancer	0.00334	0.00552	CcSEcCtD
Mexiletine—Neutropenia—Vincristine—colon cancer	0.00329	0.00544	CcSEcCtD
Mexiletine—Dysphagia—Fluorouracil—colon cancer	0.00328	0.00542	CcSEcCtD
Mexiletine—Erectile dysfunction—Vincristine—colon cancer	0.00324	0.00535	CcSEcCtD
Mexiletine—Neutropenia—Irinotecan—colon cancer	0.0032	0.00529	CcSEcCtD
Mexiletine—Angina pectoris—Fluorouracil—colon cancer	0.00319	0.00528	CcSEcCtD
Mexiletine—Speech disorder—Methotrexate—colon cancer	0.00316	0.00523	CcSEcCtD
Mexiletine—Depression—Vincristine—colon cancer	0.00313	0.00517	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.00304	0.0169	CbGpPWpGaD
Mexiletine—AHR—smooth muscle tissue—colon cancer	0.00298	0.0785	CbGeAlD
Mexiletine—CYP2B6—Metapathway biotransformation—CHST4—colon cancer	0.00294	0.0163	CbGpPWpGaD
Mexiletine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00292	0.0163	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CHST4—colon cancer	0.00288	0.016	CbGpPWpGaD
Mexiletine—Libido decreased—Capecitabine—colon cancer	0.00286	0.00473	CcSEcCtD
Mexiletine—Hot flush—Capecitabine—colon cancer	0.00283	0.00469	CcSEcCtD
Mexiletine—Amnesia—Capecitabine—colon cancer	0.00282	0.00467	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Capecitabine—colon cancer	0.00281	0.00465	CcSEcCtD
Mexiletine—Menopausal symptoms—Capecitabine—colon cancer	0.00281	0.00465	CcSEcCtD
Mexiletine—Hypoaesthesia—Vincristine—colon cancer	0.0028	0.00463	CcSEcCtD
Mexiletine—Hallucination—Vincristine—colon cancer	0.0028	0.00463	CcSEcCtD
Mexiletine—Bradycardia—Irinotecan—colon cancer	0.00279	0.00461	CcSEcCtD
Mexiletine—Agranulocytosis—Fluorouracil—colon cancer	0.00273	0.00451	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.00265	0.0148	CbGpPWpGaD
Mexiletine—Visual impairment—Irinotecan—colon cancer	0.00264	0.00437	CcSEcCtD
Mexiletine—Disturbance in sexual arousal—Capecitabine—colon cancer	0.00263	0.00435	CcSEcCtD
Mexiletine—SCN4A—renal system—colon cancer	0.00263	0.0691	CbGeAlD
Mexiletine—Hypoaesthesia—Fluorouracil—colon cancer	0.00261	0.00432	CcSEcCtD
Mexiletine—Pharyngitis—Fluorouracil—colon cancer	0.0026	0.00431	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.00253	0.014	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.00253	0.014	CbGpPWpGaD
Mexiletine—Ataxia—Capecitabine—colon cancer	0.00249	0.00412	CcSEcCtD
Mexiletine—Alopecia—Vincristine—colon cancer	0.00249	0.00411	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.00246	0.0137	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.00246	0.0137	CbGpPWpGaD
Mexiletine—Arrhythmia—Irinotecan—colon cancer	0.00245	0.00405	CcSEcCtD
Mexiletine—Liver function test abnormal—Capecitabine—colon cancer	0.00245	0.00405	CcSEcCtD
Mexiletine—Dry skin—Capecitabine—colon cancer	0.00243	0.00402	CcSEcCtD
Mexiletine—Alopecia—Irinotecan—colon cancer	0.00242	0.00401	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.00239	0.0133	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.00236	0.0131	CbGpPWpGaD
Mexiletine—AHR—digestive system—colon cancer	0.00236	0.062	CbGeAlD
Mexiletine—Arrhythmia—Fluorouracil—colon cancer	0.00234	0.00388	CcSEcCtD
Mexiletine—Alopecia—Fluorouracil—colon cancer	0.00232	0.00384	CcSEcCtD
Mexiletine—Muscle spasms—Irinotecan—colon cancer	0.00229	0.00379	CcSEcCtD
Mexiletine—Dysphagia—Capecitabine—colon cancer	0.00229	0.00379	CcSEcCtD
Mexiletine—Angina pectoris—Capecitabine—colon cancer	0.00223	0.00369	CcSEcCtD
Mexiletine—Sweating increased—Capecitabine—colon cancer	0.00223	0.00369	CcSEcCtD
Mexiletine—Ill-defined disorder—Irinotecan—colon cancer	0.00221	0.00366	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.0022	0.0122	CbGpPWpGaD
Mexiletine—Abdominal discomfort—Capecitabine—colon cancer	0.0022	0.00363	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.0022	0.0122	CbGpPWpGaD
Mexiletine—Leukopenia—Vincristine—colon cancer	0.00219	0.00363	CcSEcCtD
Mexiletine—AHR—bone marrow—colon cancer	0.00217	0.0571	CbGeAlD
Mexiletine—Vision blurred—Fluorouracil—colon cancer	0.00215	0.00356	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.00215	0.012	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.00215	0.012	CbGpPWpGaD
Mexiletine—Malaise—Irinotecan—colon cancer	0.00215	0.00356	CcSEcCtD
Mexiletine—Neutropenia—Capecitabine—colon cancer	0.00214	0.00354	CcSEcCtD
Mexiletine—Syncope—Irinotecan—colon cancer	0.00214	0.00354	CcSEcCtD
Mexiletine—Leukopenia—Irinotecan—colon cancer	0.00214	0.00353	CcSEcCtD
Mexiletine—Convulsion—Vincristine—colon cancer	0.00212	0.00351	CcSEcCtD
Mexiletine—Hypertension—Vincristine—colon cancer	0.00211	0.0035	CcSEcCtD
Mexiletine—Loss of consciousness—Irinotecan—colon cancer	0.0021	0.00347	CcSEcCtD
Mexiletine—Dermatitis exfoliative—Methotrexate—colon cancer	0.00209	0.00346	CcSEcCtD
Mexiletine—Visual disturbance—Methotrexate—colon cancer	0.00208	0.00344	CcSEcCtD
Mexiletine—AHR—vagina—colon cancer	0.00208	0.0547	CbGeAlD
Mexiletine—Hypertension—Irinotecan—colon cancer	0.00206	0.00341	CcSEcCtD
Mexiletine—Leukopenia—Fluorouracil—colon cancer	0.00205	0.00338	CcSEcCtD
Mexiletine—CYP2D6—Metapathway biotransformation—CHST4—colon cancer	0.00204	0.0114	CbGpPWpGaD
Mexiletine—Depression—Capecitabine—colon cancer	0.00204	0.00337	CcSEcCtD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.00203	0.0113	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BAX—colon cancer	0.00203	0.0113	CbGpPWpGaD
Mexiletine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00203	0.00335	CcSEcCtD
Mexiletine—Discomfort—Irinotecan—colon cancer	0.00201	0.00332	CcSEcCtD
Mexiletine—Oedema—Vincristine—colon cancer	0.002	0.00331	CcSEcCtD
Mexiletine—Convulsion—Fluorouracil—colon cancer	0.00198	0.00327	CcSEcCtD
Mexiletine—Confusional state—Irinotecan—colon cancer	0.00196	0.00325	CcSEcCtD
Mexiletine—Thrombocytopenia—Vincristine—colon cancer	0.00196	0.00324	CcSEcCtD
Mexiletine—Oedema—Irinotecan—colon cancer	0.00195	0.00322	CcSEcCtD
Mexiletine—Chest pain—Fluorouracil—colon cancer	0.00195	0.00322	CcSEcCtD
Mexiletine—Hyperhidrosis—Vincristine—colon cancer	0.00193	0.0032	CcSEcCtD
Mexiletine—Discomfort—Fluorouracil—colon cancer	0.00192	0.00318	CcSEcCtD
Mexiletine—Shock—Irinotecan—colon cancer	0.00192	0.00317	CcSEcCtD
Mexiletine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.00191	0.0106	CbGpPWpGaD
Mexiletine—Agranulocytosis—Capecitabine—colon cancer	0.00191	0.00315	CcSEcCtD
Mexiletine—Thrombocytopenia—Irinotecan—colon cancer	0.00191	0.00315	CcSEcCtD
Mexiletine—Hyperhidrosis—Irinotecan—colon cancer	0.00188	0.00311	CcSEcCtD
Mexiletine—Confusional state—Fluorouracil—colon cancer	0.00188	0.00311	CcSEcCtD
Mexiletine—Hypotension—Vincristine—colon cancer	0.00187	0.00309	CcSEcCtD
Mexiletine—Bradycardia—Capecitabine—colon cancer	0.00187	0.00309	CcSEcCtD
Mexiletine—Oedema—Fluorouracil—colon cancer	0.00186	0.00308	CcSEcCtD
Mexiletine—SCN10A—lymphoid tissue—colon cancer	0.00186	0.0489	CbGeAlD
Mexiletine—Ataxia—Methotrexate—colon cancer	0.00186	0.00307	CcSEcCtD
Mexiletine—Hepatitis—Capecitabine—colon cancer	0.00183	0.00303	CcSEcCtD
Mexiletine—Thrombocytopenia—Fluorouracil—colon cancer	0.00183	0.00302	CcSEcCtD
Mexiletine—Hypoaesthesia—Capecitabine—colon cancer	0.00182	0.00302	CcSEcCtD
Mexiletine—Liver function test abnormal—Methotrexate—colon cancer	0.00182	0.00301	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Vincristine—colon cancer	0.00182	0.00301	CcSEcCtD
Mexiletine—Pharyngitis—Capecitabine—colon cancer	0.00182	0.00301	CcSEcCtD
Mexiletine—Hypotension—Irinotecan—colon cancer	0.00182	0.00301	CcSEcCtD
Mexiletine—Paraesthesia—Vincristine—colon cancer	0.0018	0.00297	CcSEcCtD
Mexiletine—Visual impairment—Capecitabine—colon cancer	0.00177	0.00292	CcSEcCtD
Mexiletine—AHR—liver—colon cancer	0.00176	0.0462	CbGeAlD
Mexiletine—Paraesthesia—Irinotecan—colon cancer	0.00175	0.00289	CcSEcCtD
Mexiletine—Hypotension—Fluorouracil—colon cancer	0.00174	0.00288	CcSEcCtD
Mexiletine—Dyspnoea—Irinotecan—colon cancer	0.00174	0.00287	CcSEcCtD
Mexiletine—Erythema multiforme—Capecitabine—colon cancer	0.00173	0.00287	CcSEcCtD
Mexiletine—Somnolence—Irinotecan—colon cancer	0.00173	0.00286	CcSEcCtD
Mexiletine—CYP1A2—Metapathway biotransformation—CHST4—colon cancer	0.00173	0.00962	CbGpPWpGaD
Mexiletine—AHR—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.00173	0.00961	CbGpPWpGaD
Mexiletine—Fatigue—Vincristine—colon cancer	0.00172	0.00285	CcSEcCtD
Mexiletine—Dyspepsia—Irinotecan—colon cancer	0.00171	0.00283	CcSEcCtD
Mexiletine—Tinnitus—Capecitabine—colon cancer	0.00171	0.00283	CcSEcCtD
Mexiletine—Constipation—Vincristine—colon cancer	0.00171	0.00283	CcSEcCtD
Mexiletine—Pain—Vincristine—colon cancer	0.00171	0.00283	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0017	0.00281	CcSEcCtD
Mexiletine—SCN2A—vagina—colon cancer	0.00168	0.0443	CbGeAlD
Mexiletine—AHR—Adipogenesis—PPARG—colon cancer	0.00168	0.00935	CbGpPWpGaD
Mexiletine—Fatigue—Irinotecan—colon cancer	0.00168	0.00278	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—TYMS—colon cancer	0.00167	0.00931	CbGpPWpGaD
Mexiletine—Paraesthesia—Fluorouracil—colon cancer	0.00167	0.00277	CcSEcCtD
Mexiletine—Pancreatitis—Methotrexate—colon cancer	0.00167	0.00277	CcSEcCtD
Mexiletine—SCN5A—digestive system—colon cancer	0.00167	0.0439	CbGeAlD
Mexiletine—Constipation—Irinotecan—colon cancer	0.00166	0.00275	CcSEcCtD
Mexiletine—Pain—Irinotecan—colon cancer	0.00166	0.00275	CcSEcCtD
Mexiletine—Dyspnoea—Fluorouracil—colon cancer	0.00166	0.00275	CcSEcCtD
Mexiletine—Somnolence—Fluorouracil—colon cancer	0.00166	0.00274	CcSEcCtD
Mexiletine—Dyspepsia—Fluorouracil—colon cancer	0.00164	0.00271	CcSEcCtD
Mexiletine—Arrhythmia—Capecitabine—colon cancer	0.00164	0.00271	CcSEcCtD
Mexiletine—Abdominal discomfort—Methotrexate—colon cancer	0.00164	0.0027	CcSEcCtD
Mexiletine—Gastrointestinal pain—Vincristine—colon cancer	0.00163	0.0027	CcSEcCtD
Mexiletine—Alopecia—Capecitabine—colon cancer	0.00162	0.00268	CcSEcCtD
Mexiletine—Feeling abnormal—Irinotecan—colon cancer	0.0016	0.00265	CcSEcCtD
Mexiletine—Neutropenia—Methotrexate—colon cancer	0.0016	0.00264	CcSEcCtD
Mexiletine—Pain—Fluorouracil—colon cancer	0.00159	0.00264	CcSEcCtD
Mexiletine—Gastrointestinal pain—Irinotecan—colon cancer	0.00159	0.00263	CcSEcCtD
Mexiletine—Body temperature increased—Vincristine—colon cancer	0.00158	0.00261	CcSEcCtD
Mexiletine—Abdominal pain—Vincristine—colon cancer	0.00158	0.00261	CcSEcCtD
Mexiletine—Erectile dysfunction—Methotrexate—colon cancer	0.00157	0.0026	CcSEcCtD
Mexiletine—Dysgeusia—Capecitabine—colon cancer	0.00156	0.00259	CcSEcCtD
Mexiletine—Abdominal pain—Irinotecan—colon cancer	0.00154	0.00255	CcSEcCtD
Mexiletine—Body temperature increased—Irinotecan—colon cancer	0.00154	0.00255	CcSEcCtD
Mexiletine—Feeling abnormal—Fluorouracil—colon cancer	0.00154	0.00254	CcSEcCtD
Mexiletine—Muscle spasms—Capecitabine—colon cancer	0.00154	0.00254	CcSEcCtD
Mexiletine—Drowsiness—Methotrexate—colon cancer	0.00152	0.00252	CcSEcCtD
Mexiletine—Depression—Methotrexate—colon cancer	0.00152	0.00251	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00151	0.00249	CcSEcCtD
Mexiletine—Vision blurred—Capecitabine—colon cancer	0.0015	0.00249	CcSEcCtD
Mexiletine—Tremor—Capecitabine—colon cancer	0.0015	0.00247	CcSEcCtD
Mexiletine—SCN9A—Axon guidance—DCC—colon cancer	0.00148	0.00826	CbGpPWpGaD
Mexiletine—Ill-defined disorder—Capecitabine—colon cancer	0.00148	0.00245	CcSEcCtD
Mexiletine—SCN5A—vagina—colon cancer	0.00148	0.0388	CbGeAlD
Mexiletine—Body temperature increased—Fluorouracil—colon cancer	0.00147	0.00244	CcSEcCtD
Mexiletine—Hypersensitivity—Vincristine—colon cancer	0.00147	0.00244	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.00145	0.00808	CbGpPWpGaD
Mexiletine—Malaise—Capecitabine—colon cancer	0.00144	0.00238	CcSEcCtD
Mexiletine—Hypersensitivity—Irinotecan—colon cancer	0.00143	0.00237	CcSEcCtD
Mexiletine—Asthenia—Vincristine—colon cancer	0.00143	0.00237	CcSEcCtD
Mexiletine—Syncope—Capecitabine—colon cancer	0.00143	0.00237	CcSEcCtD
Mexiletine—Leukopenia—Capecitabine—colon cancer	0.00143	0.00236	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.00142	0.00791	CbGpPWpGaD
Mexiletine—Agranulocytosis—Methotrexate—colon cancer	0.00142	0.00235	CcSEcCtD
Mexiletine—Palpitations—Capecitabine—colon cancer	0.00141	0.00233	CcSEcCtD
Mexiletine—Loss of consciousness—Capecitabine—colon cancer	0.0014	0.00232	CcSEcCtD
Mexiletine—Asthenia—Irinotecan—colon cancer	0.0014	0.00231	CcSEcCtD
Mexiletine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00139	0.00772	CbGpPWpGaD
Mexiletine—SCN9A—lymph node—colon cancer	0.00138	0.0363	CbGeAlD
Mexiletine—Hypertension—Capecitabine—colon cancer	0.00138	0.00228	CcSEcCtD
Mexiletine—Hypersensitivity—Fluorouracil—colon cancer	0.00137	0.00227	CcSEcCtD
Mexiletine—Diarrhoea—Vincristine—colon cancer	0.00137	0.00226	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—colon cancer	0.00137	0.00226	CcSEcCtD
Mexiletine—SCN2A—Axon guidance—DCC—colon cancer	0.00136	0.00759	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—DCC—colon cancer	0.00136	0.00759	CbGpPWpGaD
Mexiletine—Arthralgia—Capecitabine—colon cancer	0.00136	0.00225	CcSEcCtD
Mexiletine—Chest pain—Capecitabine—colon cancer	0.00136	0.00225	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—colon cancer	0.00136	0.00224	CcSEcCtD
Mexiletine—CYP2B6—Metapathway biotransformation—CHST5—colon cancer	0.00135	0.0075	CbGpPWpGaD
Mexiletine—AHR—lymph node—colon cancer	0.00135	0.0354	CbGeAlD
Mexiletine—Discomfort—Capecitabine—colon cancer	0.00134	0.00222	CcSEcCtD
Mexiletine—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.00133	0.00742	CbGpPWpGaD
Mexiletine—Diarrhoea—Irinotecan—colon cancer	0.00133	0.0022	CcSEcCtD
Mexiletine—Dry mouth—Capecitabine—colon cancer	0.00133	0.0022	CcSEcCtD
Mexiletine—Dizziness—Vincristine—colon cancer	0.00132	0.00219	CcSEcCtD
Mexiletine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00132	0.00735	CbGpPWpGaD
Mexiletine—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	0.00132	0.00735	CbGpPWpGaD
Mexiletine—Visual impairment—Methotrexate—colon cancer	0.00132	0.00218	CcSEcCtD
Mexiletine—SCN10A—Axon guidance—DCC—colon cancer	0.00132	0.00732	CbGpPWpGaD
Mexiletine—Confusional state—Capecitabine—colon cancer	0.00131	0.00217	CcSEcCtD
Mexiletine—Oedema—Capecitabine—colon cancer	0.0013	0.00216	CcSEcCtD
Mexiletine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00129	0.0072	CbGpPWpGaD
Mexiletine—Erythema multiforme—Methotrexate—colon cancer	0.00129	0.00214	CcSEcCtD
Mexiletine—Dizziness—Irinotecan—colon cancer	0.00129	0.00213	CcSEcCtD
Mexiletine—Shock—Capecitabine—colon cancer	0.00128	0.00212	CcSEcCtD
Mexiletine—Diarrhoea—Fluorouracil—colon cancer	0.00128	0.00211	CcSEcCtD
Mexiletine—Thrombocytopenia—Capecitabine—colon cancer	0.00128	0.00211	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—colon cancer	0.00127	0.00211	CcSEcCtD
Mexiletine—Vomiting—Vincristine—colon cancer	0.00127	0.0021	CcSEcCtD
Mexiletine—Rash—Vincristine—colon cancer	0.00126	0.00208	CcSEcCtD
Mexiletine—Hyperhidrosis—Capecitabine—colon cancer	0.00126	0.00208	CcSEcCtD
Mexiletine—Dermatitis—Vincristine—colon cancer	0.00126	0.00208	CcSEcCtD
Mexiletine—Headache—Vincristine—colon cancer	0.00125	0.00207	CcSEcCtD
Mexiletine—Vomiting—Irinotecan—colon cancer	0.00124	0.00205	CcSEcCtD
Mexiletine—Dizziness—Fluorouracil—colon cancer	0.00123	0.00204	CcSEcCtD
Mexiletine—Rash—Irinotecan—colon cancer	0.00123	0.00203	CcSEcCtD
Mexiletine—Dermatitis—Irinotecan—colon cancer	0.00123	0.00203	CcSEcCtD
Mexiletine—Headache—Irinotecan—colon cancer	0.00122	0.00202	CcSEcCtD
Mexiletine—Hypotension—Capecitabine—colon cancer	0.00122	0.00201	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—colon cancer	0.00121	0.002	CcSEcCtD
Mexiletine—Nausea—Vincristine—colon cancer	0.00119	0.00196	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00119	0.00196	CcSEcCtD
Mexiletine—AHR—Circadian rythm related genes—PPARG—colon cancer	0.00119	0.0066	CbGpPWpGaD
Mexiletine—Vomiting—Fluorouracil—colon cancer	0.00119	0.00196	CcSEcCtD
Mexiletine—AHR—Adipogenesis—CTNNB1—colon cancer	0.00118	0.00658	CbGpPWpGaD
Mexiletine—Rash—Fluorouracil—colon cancer	0.00118	0.00194	CcSEcCtD
Mexiletine—Dermatitis—Fluorouracil—colon cancer	0.00117	0.00194	CcSEcCtD
Mexiletine—Paraesthesia—Capecitabine—colon cancer	0.00117	0.00194	CcSEcCtD
Mexiletine—Headache—Fluorouracil—colon cancer	0.00117	0.00193	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—colon cancer	0.00116	0.00192	CcSEcCtD
Mexiletine—Dyspnoea—Capecitabine—colon cancer	0.00116	0.00192	CcSEcCtD
Mexiletine—Nausea—Irinotecan—colon cancer	0.00116	0.00191	CcSEcCtD
Mexiletine—AHR—Adipogenesis—CDKN1A—colon cancer	0.00116	0.00643	CbGpPWpGaD
Mexiletine—Dyspepsia—Capecitabine—colon cancer	0.00115	0.0019	CcSEcCtD
Mexiletine—Fatigue—Capecitabine—colon cancer	0.00112	0.00186	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—colon cancer	0.00112	0.00185	CcSEcCtD
Mexiletine—Constipation—Capecitabine—colon cancer	0.00111	0.00184	CcSEcCtD
Mexiletine—Pain—Capecitabine—colon cancer	0.00111	0.00184	CcSEcCtD
Mexiletine—Nausea—Fluorouracil—colon cancer	0.00111	0.00183	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—colon cancer	0.0011	0.00182	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.00109	0.00606	CbGpPWpGaD
Mexiletine—Feeling abnormal—Capecitabine—colon cancer	0.00107	0.00178	CcSEcCtD
Mexiletine—CYP1A2—renal system—colon cancer	0.00107	0.0282	CbGeAlD
Mexiletine—Malaise—Methotrexate—colon cancer	0.00107	0.00177	CcSEcCtD
Mexiletine—Gastrointestinal pain—Capecitabine—colon cancer	0.00107	0.00176	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—colon cancer	0.00106	0.00176	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.00106	0.00589	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—DCC—colon cancer	0.00106	0.00589	CbGpPWpGaD
Mexiletine—SCN10A—lymph node—colon cancer	0.00105	0.0276	CbGeAlD
Mexiletine—AHR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.00105	0.00584	CbGpPWpGaD
Mexiletine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00105	0.00582	CbGpPWpGaD
Mexiletine—Body temperature increased—Capecitabine—colon cancer	0.00103	0.0017	CcSEcCtD
Mexiletine—Abdominal pain—Capecitabine—colon cancer	0.00103	0.0017	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—colon cancer	0.00103	0.0017	CcSEcCtD
Mexiletine—CYP2B6—renal system—colon cancer	0.00103	0.027	CbGeAlD
Mexiletine—Chest pain—Methotrexate—colon cancer	0.00101	0.00167	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—colon cancer	0.00101	0.00167	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—colon cancer	0.001	0.00165	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—colon cancer	0.000978	0.00162	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.000976	0.00543	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—DCC—colon cancer	0.000974	0.00541	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—DCC—colon cancer	0.000974	0.00541	CbGpPWpGaD
Mexiletine—CYP2E1—renal system—colon cancer	0.000965	0.0254	CbGeAlD
Mexiletine—Hypersensitivity—Capecitabine—colon cancer	0.00096	0.00159	CcSEcCtD
Mexiletine—AHR—Adipogenesis—TGFB1—colon cancer	0.000956	0.00532	CbGpPWpGaD
Mexiletine—Thrombocytopenia—Methotrexate—colon cancer	0.00095	0.00157	CcSEcCtD
Mexiletine—SCN10A—Developmental Biology—DCC—colon cancer	0.000939	0.00522	CbGpPWpGaD
Mexiletine—Hyperhidrosis—Methotrexate—colon cancer	0.000938	0.00155	CcSEcCtD
Mexiletine—CYP2D6—Metapathway biotransformation—CHST5—colon cancer	0.000937	0.00521	CbGpPWpGaD
Mexiletine—Asthenia—Capecitabine—colon cancer	0.000935	0.00155	CcSEcCtD
Mexiletine—SCN5A—Axon guidance—DCC—colon cancer	0.000925	0.00514	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000924	0.00514	CbGpPWpGaD
Mexiletine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00092	0.00511	CbGpPWpGaD
Mexiletine—SCN9A—L1CAM interactions—SRC—colon cancer	0.000914	0.00508	CbGpPWpGaD
Mexiletine—Hypotension—Methotrexate—colon cancer	0.000906	0.0015	CcSEcCtD
Mexiletine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000901	0.00501	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HNF4A—colon cancer	0.000892	0.00496	CbGpPWpGaD
Mexiletine—Diarrhoea—Capecitabine—colon cancer	0.000892	0.00147	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000884	0.00146	CcSEcCtD
Mexiletine—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.00088	0.0049	CbGpPWpGaD
Mexiletine—CYP1A2—digestive system—colon cancer	0.00088	0.0231	CbGeAlD
Mexiletine—Paraesthesia—Methotrexate—colon cancer	0.000871	0.00144	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—colon cancer	0.000865	0.00143	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—colon cancer	0.000862	0.00143	CcSEcCtD
Mexiletine—Dizziness—Capecitabine—colon cancer	0.000862	0.00143	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—colon cancer	0.000854	0.00141	CcSEcCtD
Mexiletine—CYP2B6—lymphoid tissue—colon cancer	0.000854	0.0224	CbGeAlD
Mexiletine—AHR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.00085	0.00473	CbGpPWpGaD
Mexiletine—CYP2B6—digestive system—colon cancer	0.000843	0.0222	CbGeAlD
Mexiletine—SCN4A—L1CAM interactions—SRC—colon cancer	0.000839	0.00467	CbGpPWpGaD
Mexiletine—SCN2A—L1CAM interactions—SRC—colon cancer	0.000839	0.00467	CbGpPWpGaD
Mexiletine—Fatigue—Methotrexate—colon cancer	0.000836	0.00138	CcSEcCtD
Mexiletine—AHR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000832	0.00462	CbGpPWpGaD
Mexiletine—Pain—Methotrexate—colon cancer	0.00083	0.00137	CcSEcCtD
Mexiletine—Vomiting—Capecitabine—colon cancer	0.000828	0.00137	CcSEcCtD
Mexiletine—Rash—Capecitabine—colon cancer	0.000822	0.00136	CcSEcCtD
Mexiletine—Dermatitis—Capecitabine—colon cancer	0.000821	0.00136	CcSEcCtD
Mexiletine—SCN4A—Developmental Biology—HNF4A—colon cancer	0.00082	0.00456	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HNF4A—colon cancer	0.00082	0.00456	CbGpPWpGaD
Mexiletine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—colon cancer	0.000818	0.00455	CbGpPWpGaD
Mexiletine—Headache—Capecitabine—colon cancer	0.000816	0.00135	CcSEcCtD
Mexiletine—SCN10A—L1CAM interactions—SRC—colon cancer	0.000809	0.0045	CbGpPWpGaD
Mexiletine—CYP2E1—lymphoid tissue—colon cancer	0.000801	0.0211	CbGeAlD
Mexiletine—SCN9A—L1CAM interactions—EGFR—colon cancer	0.000801	0.00445	CbGpPWpGaD
Mexiletine—Feeling abnormal—Methotrexate—colon cancer	0.000799	0.00132	CcSEcCtD
Mexiletine—CYP1A2—Metapathway biotransformation—CHST5—colon cancer	0.000794	0.00442	CbGpPWpGaD
Mexiletine—Gastrointestinal pain—Methotrexate—colon cancer	0.000793	0.00131	CcSEcCtD
Mexiletine—CYP2E1—digestive system—colon cancer	0.000791	0.0208	CbGeAlD
Mexiletine—SCN10A—Developmental Biology—HNF4A—colon cancer	0.00079	0.00439	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000786	0.00437	CbGpPWpGaD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000778	0.00433	CbGpPWpGaD
Mexiletine—CYP3A4—renal system—colon cancer	0.000776	0.0204	CbGeAlD
Mexiletine—AHR—Circadian rythm related genes—EP300—colon cancer	0.000776	0.00432	CbGpPWpGaD
Mexiletine—Nausea—Capecitabine—colon cancer	0.000774	0.00128	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—colon cancer	0.000767	0.00127	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—colon cancer	0.000767	0.00127	CcSEcCtD
Mexiletine—CYP2D6—renal system—colon cancer	0.000764	0.0201	CbGeAlD
Mexiletine—CYP2B6—vagina—colon cancer	0.000745	0.0196	CbGeAlD
Mexiletine—SCN2A—L1CAM interactions—EGFR—colon cancer	0.000736	0.00409	CbGpPWpGaD
Mexiletine—SCN4A—L1CAM interactions—EGFR—colon cancer	0.000736	0.00409	CbGpPWpGaD
Mexiletine—Hypersensitivity—Methotrexate—colon cancer	0.000715	0.00118	CcSEcCtD
Mexiletine—SCN10A—L1CAM interactions—EGFR—colon cancer	0.00071	0.00395	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—TP53—colon cancer	0.000698	0.00388	CbGpPWpGaD
Mexiletine—Asthenia—Methotrexate—colon cancer	0.000696	0.00115	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—colon cancer	0.000664	0.0011	CcSEcCtD
Mexiletine—SCN5A—Developmental Biology—DCC—colon cancer	0.00066	0.00367	CbGpPWpGaD
Mexiletine—CYP1A2—liver—colon cancer	0.000655	0.0172	CbGeAlD
Mexiletine—Dizziness—Methotrexate—colon cancer	0.000641	0.00106	CcSEcCtD
Mexiletine—CYP3A4—digestive system—colon cancer	0.000637	0.0167	CbGeAlD
Mexiletine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00063	0.00351	CbGpPWpGaD
Mexiletine—CYP2B6—liver—colon cancer	0.000628	0.0165	CbGeAlD
Mexiletine—CYP2D6—digestive system—colon cancer	0.000627	0.0165	CbGeAlD
Mexiletine—Vomiting—Methotrexate—colon cancer	0.000617	0.00102	CcSEcCtD
Mexiletine—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000613	0.00341	CbGpPWpGaD
Mexiletine—Rash—Methotrexate—colon cancer	0.000612	0.00101	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—colon cancer	0.000611	0.00101	CcSEcCtD
Mexiletine—Headache—Methotrexate—colon cancer	0.000608	0.00101	CcSEcCtD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000601	0.00334	CbGpPWpGaD
Mexiletine—AHR—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.00059	0.00328	CbGpPWpGaD
Mexiletine—CYP2E1—liver—colon cancer	0.00059	0.0155	CbGeAlD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000578	0.00321	CbGpPWpGaD
Mexiletine—Nausea—Methotrexate—colon cancer	0.000576	0.000953	CcSEcCtD
Mexiletine—SCN5A—L1CAM interactions—SRC—colon cancer	0.000569	0.00316	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HNF4A—colon cancer	0.000556	0.00309	CbGpPWpGaD
Mexiletine—AHR—Circadian rythm related genes—TP53—colon cancer	0.000555	0.00309	CbGpPWpGaD
Mexiletine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000541	0.00301	CbGpPWpGaD
Mexiletine—SCN5A—L1CAM interactions—EGFR—colon cancer	0.000499	0.00277	CbGpPWpGaD
Mexiletine—CYP3A4—liver—colon cancer	0.000474	0.0125	CbGeAlD
Mexiletine—CYP2D6—liver—colon cancer	0.000467	0.0123	CbGeAlD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CASP3—colon cancer	0.000443	0.00246	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—colon cancer	0.000427	0.00237	CbGpPWpGaD
Mexiletine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000418	0.00232	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—EP300—colon cancer	0.000397	0.00221	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—PPARG—colon cancer	0.000387	0.00215	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CA7—colon cancer	0.000386	0.00215	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CA7—colon cancer	0.000378	0.0021	CbGpPWpGaD
Mexiletine—SCN5A—SIDS Susceptibility Pathways—VEGFA—colon cancer	0.000376	0.00209	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—PPARG—colon cancer	0.000356	0.00198	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—PPARG—colon cancer	0.000356	0.00198	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—SRC—colon cancer	0.000345	0.00192	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—PPARG—colon cancer	0.000343	0.00191	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—VEGFA—colon cancer	0.000336	0.00187	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000334	0.00186	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—NRAS—colon cancer	0.000332	0.00185	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—SRC—colon cancer	0.000317	0.00176	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—SRC—colon cancer	0.000317	0.00176	CbGpPWpGaD
Mexiletine—CYP1A2—Arachidonic acid metabolism—PTGS2—colon cancer	0.000313	0.00174	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—VEGFA—colon cancer	0.000309	0.00172	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—VEGFA—colon cancer	0.000309	0.00172	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—SRC—colon cancer	0.000306	0.0017	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—NRAS—colon cancer	0.000305	0.0017	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—NRAS—colon cancer	0.000305	0.0017	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—EGFR—colon cancer	0.000303	0.00168	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—VEGFA—colon cancer	0.000298	0.00166	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—NRAS—colon cancer	0.000294	0.00164	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000292	0.00163	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—KRAS—colon cancer	0.000286	0.00159	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000278	0.00155	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000278	0.00155	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—EGFR—colon cancer	0.000278	0.00155	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—EGFR—colon cancer	0.000278	0.00155	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—CTNNB1—colon cancer	0.000273	0.00152	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.00027	0.0015	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.00027	0.0015	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CA7—colon cancer	0.000268	0.00149	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—EGFR—colon cancer	0.000268	0.00149	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000263	0.00146	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—KRAS—colon cancer	0.000263	0.00146	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—KRAS—colon cancer	0.000263	0.00146	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.00026	0.00145	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EP300—colon cancer	0.000253	0.00141	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—KRAS—colon cancer	0.000253	0.00141	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—CTNNB1—colon cancer	0.00025	0.00139	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—CTNNB1—colon cancer	0.00025	0.00139	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—SRC—colon cancer	0.000246	0.00137	CbGpPWpGaD
Mexiletine—SCN9A—Axon guidance—HRAS—colon cancer	0.000243	0.00135	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	0.000242	0.00135	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	0.000242	0.00134	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—CTNNB1—colon cancer	0.000242	0.00134	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—PPARG—colon cancer	0.000241	0.00134	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—VEGFA—colon cancer	0.00024	0.00133	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	0.000237	0.00132	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	0.000237	0.00132	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—NRAS—colon cancer	0.000237	0.00132	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CHST5—colon cancer	0.000234	0.0013	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ODC1—colon cancer	0.000234	0.0013	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EP300—colon cancer	0.000233	0.00129	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EP300—colon cancer	0.000233	0.00129	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ODC1—colon cancer	0.000229	0.00127	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CHST5—colon cancer	0.000229	0.00127	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CA7—colon cancer	0.000227	0.00126	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—SRC—colon cancer	0.000226	0.00126	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—SRC—colon cancer	0.000226	0.00126	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EP300—colon cancer	0.000224	0.00125	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	0.000224	0.00125	CbGpPWpGaD
Mexiletine—SCN4A—Axon guidance—HRAS—colon cancer	0.000223	0.00124	CbGpPWpGaD
Mexiletine—SCN2A—Axon guidance—HRAS—colon cancer	0.000223	0.00124	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—VEGFA—colon cancer	0.00022	0.00123	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—VEGFA—colon cancer	0.00022	0.00123	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—TGFB1—colon cancer	0.00022	0.00122	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—SRC—colon cancer	0.000218	0.00121	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—NRAS—colon cancer	0.000218	0.00121	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—NRAS—colon cancer	0.000218	0.00121	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—EGFR—colon cancer	0.000216	0.0012	CbGpPWpGaD
Mexiletine—SCN10A—Axon guidance—HRAS—colon cancer	0.000215	0.0012	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—SRC—colon cancer	0.000215	0.0012	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—VEGFA—colon cancer	0.000213	0.00118	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—NRAS—colon cancer	0.00021	0.00117	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—VEGFA—colon cancer	0.000209	0.00116	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—NRAS—colon cancer	0.000207	0.00115	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—KRAS—colon cancer	0.000204	0.00113	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—TGFB1—colon cancer	0.000202	0.00113	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—TGFB1—colon cancer	0.000202	0.00113	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—EGFR—colon cancer	0.000198	0.0011	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—EGFR—colon cancer	0.000198	0.0011	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—TGFB1—colon cancer	0.000195	0.00109	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—EGFR—colon cancer	0.000191	0.00106	CbGpPWpGaD
Mexiletine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	0.00019	0.00106	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—EGFR—colon cancer	0.000189	0.00105	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—KRAS—colon cancer	0.000187	0.00104	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—KRAS—colon cancer	0.000187	0.00104	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—KRAS—colon cancer	0.000181	0.00101	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—KRAS—colon cancer	0.000178	0.00099	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CA7—colon cancer	0.000175	0.000975	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—HRAS—colon cancer	0.000173	0.000964	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—CTNNB1—colon cancer	0.00017	0.000944	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CHST5—colon cancer	0.000163	0.000904	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ODC1—colon cancer	0.000163	0.000904	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—HRAS—colon cancer	0.000159	0.000886	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—HRAS—colon cancer	0.000159	0.000886	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EP300—colon cancer	0.000158	0.000878	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—HRAS—colon cancer	0.000154	0.000854	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—SRC—colon cancer	0.000153	0.000853	CbGpPWpGaD
Mexiletine—SCN9A—Developmental Biology—AKT1—colon cancer	0.000153	0.000851	CbGpPWpGaD
Mexiletine—SCN5A—Axon guidance—HRAS—colon cancer	0.000151	0.000842	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—VEGFA—colon cancer	0.000149	0.000831	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—NRAS—colon cancer	0.000148	0.000821	CbGpPWpGaD
Mexiletine—SCN2A—Developmental Biology—AKT1—colon cancer	0.000141	0.000782	CbGpPWpGaD
Mexiletine—SCN4A—Developmental Biology—AKT1—colon cancer	0.000141	0.000782	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CHST5—colon cancer	0.000138	0.000766	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ODC1—colon cancer	0.000138	0.000766	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—TGFB1—colon cancer	0.000137	0.000763	CbGpPWpGaD
Mexiletine—SCN10A—Developmental Biology—AKT1—colon cancer	0.000136	0.000754	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—EGFR—colon cancer	0.000135	0.000748	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—KRAS—colon cancer	0.000127	0.000707	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—HRAS—colon cancer	0.000108	0.000601	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CHST5—colon cancer	0.000106	0.000591	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ODC1—colon cancer	0.000106	0.000591	CbGpPWpGaD
Mexiletine—SCN5A—Developmental Biology—AKT1—colon cancer	9.54e-05	0.00053	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCB1—colon cancer	6.18e-05	0.000344	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMS—colon cancer	6.07e-05	0.000337	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCB1—colon cancer	6.05e-05	0.000337	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMS—colon cancer	5.94e-05	0.000331	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.68e-05	0.000316	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.47e-05	0.000249	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PPARG—colon cancer	4.3e-05	0.000239	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCB1—colon cancer	4.29e-05	0.000239	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMS—colon cancer	4.22e-05	0.000235	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PPARG—colon cancer	4.21e-05	0.000234	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.72e-05	0.000207	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCB1—colon cancer	3.64e-05	0.000202	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMS—colon cancer	3.57e-05	0.000199	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—colon cancer	3.38e-05	0.000188	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—colon cancer	3.31e-05	0.000184	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PPARG—colon cancer	2.99e-05	0.000166	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—EP300—colon cancer	2.81e-05	0.000156	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCB1—colon cancer	2.81e-05	0.000156	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMS—colon cancer	2.76e-05	0.000153	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—EP300—colon cancer	2.75e-05	0.000153	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.75e-05	0.000153	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PPARG—colon cancer	2.53e-05	0.000141	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—colon cancer	2.35e-05	0.000131	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—colon cancer	2.08e-05	0.000116	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—colon cancer	2.04e-05	0.000113	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—colon cancer	1.99e-05	0.000111	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—EP300—colon cancer	1.95e-05	0.000109	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARG—colon cancer	1.95e-05	0.000109	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—colon cancer	1.7e-05	9.45e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—colon cancer	1.66e-05	9.26e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—EP300—colon cancer	1.66e-05	9.21e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—colon cancer	1.54e-05	8.55e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—colon cancer	1.45e-05	8.04e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—EP300—colon cancer	1.28e-05	7.11e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—colon cancer	1.23e-05	6.81e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—colon cancer	1.18e-05	6.57e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—colon cancer	1e-05	5.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—colon cancer	9.45e-06	5.26e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—colon cancer	7.72e-06	4.3e-05	CbGpPWpGaD
